Integrated Historical Balance Sheet
IDHC Stock | 0.44 0.01 2.22% |
Trend analysis of Integrated Diagnostics Holdings balance sheet accounts such as Other Current Liabilities of 412 M or Total Current Liabilities of 880.3 M provides information on Integrated Diagnostics' total assets, liabilities, and equity, which is the actual value of Integrated Diagnostics to its prevalent stockholders. By breaking down trends over time using Integrated Diagnostics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Integrated Diagnostics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Integrated Diagnostics is a good buy for the upcoming year.
Integrated Diagnostics Inventory |
|
Integrated |
About Integrated Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Integrated Diagnostics at a specified time, usually calculated after every quarter, six months, or one year. Integrated Diagnostics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Integrated Diagnostics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Integrated currently owns. An asset can also be divided into two categories, current and non-current.
Integrated Diagnostics Balance Sheet Chart
Add Fundamental
Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.Most accounts from Integrated Diagnostics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Integrated Diagnostics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integrated Diagnostics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Integrated Diagnostics' Other Current Assets are comparatively stable compared to the past year. Property Plant And Equipment Gross is likely to gain to about 3.4 B in 2024, whereas Other Current Liabilities is likely to drop slightly above 412 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 98.1M | 116.4M | 1.2B | 1.2B | Total Assets | 6.2B | 5.3B | 5.8B | 4.1B |
Integrated Diagnostics balance sheet Correlations
Click cells to compare fundamentals
Integrated Diagnostics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Integrated Diagnostics balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 3.8B | 4.2B | 6.2B | 5.3B | 5.8B | 4.1B | |
Short Long Term Debt Total | 444.8M | 552.1M | 98.1M | 116.4M | 1.2B | 1.2B | |
Other Current Liab | 374.0M | 488.3M | 1.4B | 871.0M | 679.8M | 412.0M | |
Total Current Liabilities | 828.2M | 1.0B | 2.3B | 1.5B | 1.3B | 880.3M | |
Total Stockholder Equity | 2.2B | 2.3B | 2.6B | 2.2B | 2.7B | 2.4B | |
Property Plant And Equipment Net | 1.1B | 1.1B | 1.5B | 1.9B | 2.1B | 2.2B | |
Net Debt | 35.9M | (48.1M) | (793.4M) | (532.1M) | 504.9M | 530.2M | |
Retained Earnings | 456.7M | 603.3M | 1.6B | 783.1M | 1.3B | 1.3B | |
Accounts Payable | 145.2M | 177.6M | 311.3M | 269.8M | 271.7M | 165.7M | |
Cash | 408.9M | 600.1M | 891.5M | 648.5M | 674.3M | 572.3M | |
Non Current Assets Total | 2.7B | 2.8B | 3.2B | 3.7B | 3.8B | 2.8B | |
Non Currrent Assets Other | (1K) | 276.6M | 1.5B | 18.1M | 20.8M | 19.7M | |
Cash And Short Term Investments | 630.5M | 876.8M | 2.4B | 815.9M | 860.5M | 815.7M | |
Net Receivables | 261.7M | 326.8M | 373.9M | 397.5M | 571.5M | 600.1M | |
Good Will | 1.3B | 1.3B | 1.3B | 1.3B | 1.3B | 1.4B | |
Liabilities And Stockholders Equity | 3.8B | 4.2B | 6.2B | 5.3B | 5.8B | 4.1B | |
Non Current Liabilities Total | 567.0M | 741.7M | 1.1B | 1.4B | 1.4B | 1.5B | |
Inventory | 84.3M | 100.1M | 222.6M | 265.5M | 374.7M | 393.4M | |
Other Current Assets | 61.4M | 56.7M | 95.9M | 146.4M | 155.7M | 163.5M | |
Other Stockholder Equity | 1.1B | 1.1B | 1.1B | 1.1B | (427.1M) | (405.8M) | |
Total Liab | 1.4B | 1.8B | 3.4B | 2.8B | 2.7B | 1.5B | |
Property Plant And Equipment Gross | 1.1B | 1.1B | 2.1B | 2.8B | 3.2B | 3.4B | |
Total Current Assets | 1.0B | 1.4B | 3.0B | 1.6B | 2.0B | 1.3B | |
Accumulated Other Comprehensive Income | (387.7M) | (482.7M) | (1.1B) | (780.8M) | (753.2M) | (715.6M) | |
Short Term Debt | 87.1M | 85.9M | 137.2M | 171.4M | 220.4M | 231.4M | |
Intangible Assets | 398.6M | 399.8M | 402.5M | 418.2M | 422.9M | 335.8M | |
Other Liab | 196.8M | 209.3M | 275.5M | 371.3M | 427.0M | 222.5M | |
Net Tangible Assets | 597.6M | 554.7M | 610.2M | 924.0M | 1.1B | 551.2M | |
Long Term Debt | 81.3M | 67.6M | 76.3M | 93.8M | 67.5M | 58.8M | |
Property Plant Equipment | 705.8M | 1.0B | 1.1B | 1.5B | 1.7B | 1.8B | |
Short Term Investments | 221.6M | 276.6M | 1.5B | 167.4M | 186.3M | 365.1M | |
Capital Lease Obligations | 338.1M | 459.0M | 760.7M | 1.1B | 1.1B | 556.7M | |
Net Invested Capital | 2.3B | 2.4B | 2.7B | 2.3B | 2.8B | 2.7B | |
Net Working Capital | 209.7M | 351.0M | 693.6M | 160.2M | 686.9M | 468.6M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.